Literature DB >> 28460225

Evaluation of the toxicological properties and anti-inflammatory mechanism of Hemerocallis citrina in LPS-induced depressive-like mice.

Cheng-Fu Li1, Xue-Qin Chen2, Shao-Mei Chen2, Xue-Mei Chen2, Di Geng3, Qing Liu3, Li-Tao Yi3.   

Abstract

Hemerocallis citrina Baroni (Liliaceae), a Liliaceae plant, has been widely used in food and traditional medicine. This study investigated the safety of ethanol extracts from Hemerocallis citrina (HCE) after oral treatment (p.o.) and evaluating the anti-inflammatory mechanism of HCE in a lipopolysaccharide (LPS)-induced depressive-like model. First, in an 8-week experimental procedure, blood and tissue samples collected from mice were used for biochemical and histopathological analysis every two weeks. Neither the body weight nor relative organ weights were affected by HCE administration. Only the total cholesterol levels were decreased by HCE administration. Histopathological analysis showed no significant liver and kidney changes caused by HCE. In addition, in an LPS-induced mouse depressive-like model, HCE significantly reversed the reduction of sucrose preference with LPS. The results also indicated that LPS activated the nuclear factor-κB (NF-κB), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression in the prefrontal cortex. In contrast, these activations were normalized by HCE pretreatment. In summary, our study provided essential evidence for the safety of Hemerocallis citrina in both food and medicine. The results also demonstrated that HCE exhibited antidepressant-like effects that might be related to inhibition of the NF-κB signaling pathway.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Depression; Hemerocallis citrina; Inflammation; Lipopolysaccharide (LPS); Toxicological evaluation

Mesh:

Substances:

Year:  2017        PMID: 28460225     DOI: 10.1016/j.biopha.2017.04.089

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Ethyl Acetate Fraction of Hemerocallis citrina Baroni Decreases Tert-butyl Hydroperoxide-Induced Oxidative Stress Damage in BRL-3A Cells.

Authors:  Jing Wang; Dongmei Hu; Jing Hou; Shushu Li; Weiping Wang; Jun Li; Jie Bai
Journal:  Oxid Med Cell Longev       Date:  2018-11-08       Impact factor: 6.543

Review 2.  Recent Studies on Anti-Depressant Bioactive Substances in Selected Species from the Genera Hemerocallis and Gladiolus: A Systematic Review.

Authors:  Renata Matraszek-Gawron; Mirosława Chwil; Paulina Terlecka; Michał M Skoczylas
Journal:  Pharmaceuticals (Basel)       Date:  2019-11-25

Review 3.  Chinese Herbal Medicine for the Treatment of Depression: Effects on the Neuroendocrine-Immune Network.

Authors:  Chan Li; Bishan Huang; Yuan-Wei Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-14

4.  The chromosome-level Hemerocallis citrina Borani genome provides new insights into the rutin biosynthesis and the lack of colchicine.

Authors:  Zhixing Qing; Jinghong Liu; Xinxin Yi; Xiubin Liu; Guoan Hu; Jia Lao; Wei He; Zihui Yang; Xiaoyan Zou; Mengshan Sun; Peng Huang; Jianguo Zeng
Journal:  Hortic Res       Date:  2021-04-07       Impact factor: 6.793

5.  Study on the Sleep-Improvement Effects of Hemerocallis citrina Baroni in Drosophila melanogaster and Targeted Screening to Identify Its Active Components and Mechanism.

Authors:  Yuxuan Liang; Riming Huang; Yongchun Chen; Jing Zhong; Jie Deng; Ziyi Wang; Zhuojun Wu; Meiying Li; Hong Wang; Yuanming Sun
Journal:  Foods       Date:  2021-04-17

Review 6.  Extracellular Vesicles: Emerging Roles in Developing Therapeutic Approach and Delivery Tool of Chinese Herbal Medicine for the Treatment of Depressive Disorder.

Authors:  Qian Wu; Wen-Zhen Duan; Jian-Bei Chen; Xiao-Peng Zhao; Xiao-Juan Li; Yue-Yun Liu; Qing-Yu Ma; Zhe Xue; Jia-Xu Chen
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

7.  Antidepressant-like activity, active components and related mechanism of Hemerocallis citrina Baroni extracts.

Authors:  Jinghong Liu; Tian Ye; Shuaiyong Yang; Xiaohong Zhong; Wei He; Mengtao Xu; Jinpeng Fang; Miao Deng; Ning Xu; Jianguo Zeng; Zhixing Qing
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.